Aerovate Therapeutics Inc (AVTE) — Defensive Interval Ratio
Aerovate Therapeutics Inc (AVTE) has a Defensive Interval Ratio of 4831 days as of March 2025. Defensive assets of $31.99 Million (cash $-, short-term investments $31.99 Million, receivables $-) cover 4831 days of daily cash needs of $6.62K/day. See working capital position of Aerovate Therapeutics Inc to evaluate short-term liquidity relative to the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Aerovate Therapeutics Inc Defensive Interval Ratio (2020–2024)
This chart shows how Aerovate Therapeutics Inc's Defensive Interval Ratio has evolved across 5 annual periods from 2020 to 2024. As of March 2025, the ratio stands at 4831 days, meaning defensive assets of $31.99 Million can fund 4831 days of operations without new revenue. See Aerovate Therapeutics Inc (AVTE) balance sheet quality index to measure how much of total assets are equity-financed.
Annual Defensive Interval Ratio for Aerovate Therapeutics Inc (2020–2024)
The table below presents the year-by-year Defensive Interval Ratio for Aerovate Therapeutics Inc from 2020 to 2024, covering 5 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see Aerovate Therapeutics Inc stock valuation.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2024 | 4279 days | $44.87 Million | $10.49K/day | $- | $44.87 Million | ▲ +2231 days |
| 2023 | 2048 days | $98.95 Million | $48.32K/day | $- | $98.95 Million | ▼ -2963 days |
| 2022 | 5010 days | $106.82 Million | $21.32K/day | $- | $106.82 Million | ▼ -11190 days |
| 2021 | 16200 days | $113.18 Million | $6.99K/day | $- | $113.18 Million | ▲ +16200 days |
| 2020 | 0 days | $0.00 | $4.86K/day | $- | $0.00 | — |